Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy-Reference-Cited by-同舟云学术

Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy

Published:2020-02-19 Issue:5 Volume:95 Page:456-464
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Roumenina Lubka T.¹^ORCID,Chadebech Philippe²³^ORCID,Bodivit Gwellaouen²³,Vieira‐Martins Paula⁴,Grunenwald Anne¹,Boudhabhay Idris¹,Poillerat Victoria¹,Pakdaman Sadaf²³,Kiger Laurent³,Jouard Alicia²³,Audureau Etienne⁵,Pirenne France²³^ORCID,Galactéros Frédéric³⁶,Frémeaux‐Bacchi Véronique¹⁴,Bartolucci Pablo³⁶

Affiliation:

1. Centre de Recherche des CordeliersINSERM, Sorbonne Université, Université de Paris Paris France

2. Etablissement Français du SangIle‐de‐France, Hôpital Henri‐Mondor, AP‐HP Créteil France

3. INSERM U955 équipe 2, Institut Mondor de Recherche Biomédicale (IMRB)Université Paris‐Est‐Créteil (UPEC), Créteil, France; and Laboratoire d'excellence GR‐Ex Paris France

4. Service d'Immunologie Biologique, Hôpital Européen Georges‐PompidouAssistance Publique—Hôpitaux de Paris, AP‐HP Paris France

5. Sickle Cell Referral Center, Service de Médecine InterneHôpital Henri‐Mondor, AP‐HP Créteil France

6. Service de Santé PubliqueHôpital Henri‐Mondor, AP‐HP Créteil France

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25742

Reference33 articles.

1. Pathophysiology of Sickle Cell Disease

2. Complement System Part I â€“ Molecular Mechanisms of Activation and Regulation